• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YANG Jingru, MA Yuhong, HUANG Dechun, QIAN Hongliang, CHEN Wei. Progress of intelligent-responsive insulin delivery mediated by glucose oxidase[J]. Journal of China Pharmaceutical University, 2021, 52(6): 663-674. DOI: 10.11665/j.issn.1000-5048.20210603
Citation: YANG Jingru, MA Yuhong, HUANG Dechun, QIAN Hongliang, CHEN Wei. Progress of intelligent-responsive insulin delivery mediated by glucose oxidase[J]. Journal of China Pharmaceutical University, 2021, 52(6): 663-674. DOI: 10.11665/j.issn.1000-5048.20210603

Progress of intelligent-responsive insulin delivery mediated by glucose oxidase

Funds: This study was supported by the National Natural Science Foundation of China (No.51973233)
More Information
  • Received Date: August 07, 2021
  • Revised Date: October 25, 2021
  • The delivery of exogenous insulin is very important for the treatment of type 1 and advanced type 2 diabetes.Traditional injectable administration is prone to cause hypoglycemia, while the intelligent insulin system has the advantages of safety, long-term effectiveness, and high responsiveness.Glucose oxidase (GOx) can consume O2 and catalyze glucose to produce gluconic acid and H2O2.Therefore, the O2 level, H2O2 content and pH of GOx system are closely related to the glucose level in the system.This review introduces the application of GOx in closed-loop insulin delivery systems at home and abroad in recent years, which can be divided into single response and multiple response of pH-response, hypoxia-response, and H2O2-response according to the mechanism.It also discusses the opportunities and challenge facing by the application of GOx in the future.
  • [1]
    . J China Pharm Univ (中国药科大学学报),2011,42(2):97-106.
    [2]
    van Dieren S,Beulens JWJ,van der Schouw YT,et al. The global burden of diabetes and its complications:an emerging pandemic[J]. Eur J Cardiovasc Prev Rehabilitation,2010,17(Suppl 1):S3-S8.
    [3]
    Frizziero L,Calciati A,Torresin T,et al. Diabetic macular edema treated with 577-nm subthreshold micropulse laser:a real-life,long-term study[J]. J Pers Med,2021,11(5):405.
    [4]
    Ma RJ,Shi LQ. Phenylboronic acid-based glucose-responsive polymeric nanoparticles:synthesis and applications in drug delivery[J]. Polym Chem,2014,5(5):1503-1518.
    [5]
    Li CY,Huang WL,Qian H. Advances in the research of long-acting strategy of insulin and GLP-1 analogs[J]. J China Pharm Univ (中国药科大学学报),2018,49(6):660-670.
    [6]
    Chai ZH,Dong HY,Sun XY,et al. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice[J]. Int J Biol Macromol,2020,159:640-647.
    [7]
    Mo R,Jiang TY,Di J,et al. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery[J]. Chem Soc Rev,2014,43(10):3595-3629.
    [8]
    Wang J,Wang Z,Yu J,et al. Glucose-responsive insulin and delivery systems:innovation and translation[J]. Adv Mater,2020,32(13):e1902004.
    [9]
    Ravaine V,Ancla C,Catargi B. Chemically controlled closed-loop insulin delivery[J]. J Control Release,2008,132(1):2-11.
    [10]
    Wu Q,Wang L,Yu H,et al. Organization of glucose-responsive systems and their properties[J]. Chem Rev,2011,111(12):7855-7875.
    [11]
    Zhao L,Wang L,Zhang Y,et al. Glucose oxidase-based glucose-sensitive drug delivery for diabetes treatment[J]. Polymers (Basel),2017,9(7). DOI:10.3390/polym9070255.
    [12]
    Zhang M,Song CC,Du FS,et al. Supersensitive oxidation-responsive biodegradable PEG hydrogels for glucose-triggered insulin delivery[J]. ACS Appl Mater Interfaces,2017,9(31):25905-25914.
    [13]
    Dong Y,Wang W,Veiseh O,et al. Injectable and glucose-responsive hydrogels based on boronic acid-glucose complexation[J]. Langmuir,2016,32(34):8743-8747.
    [14]
    Liu XY,Li C,Lv J,et al. Glucose and H2O2 dual-responsive polymeric micelles for the self-regulated release of insulin[J]. ACS Appl Bio Mater,2020,3(3):1598-1606.
    [15]
    Gordijo CR,Koulajian K,Shuhendler AJ,et al. Nanotechnology-enabled closed loop insulin delivery device:in vitro and in vivo evaluation of glucose-regulated insulin release for diabetes control[J]. Adv Funct Mater,2011,21(1):73-82.
    [16]
    Wu Z,Zhang S,Zhang X,et al. Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release[J]. J Pharm Sci,2011,100(6):2278-2286.
    [17]
    Gu Z,Dang TT,Ma M,et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery[J]. ACS Nano,2013,7(8):6758-6766.
    [18]
    Anirudhan TS,Nair AS,Nair SS. Enzyme coated beta-cyclodextrin for effective adsorption and glucose-responsive closed-loop insulin delivery[J]. Int J Biol Macromol,2016,91:818-827.
    [19]
    Kim MY,Kim J. Chitosan microgels embedded with catalase nanozyme-loaded mesocellular silica foam for glucose-responsive drug delivery[J]. ACS Biomater Sci Eng,2017,3(4):572-578.
    [20]
    Di J,Yu JC,Ye YQ,et al. Engineering synthetic insulin-secreting cells using hyaluronic acid microgels integrated with glucose-responsive nanoparticles[J]. Cell Mol Bioeng,2015,8(3):445-454.
    [21]
    Fu Y,Liu W,Wang LY,et al. Erythrocyte-membrane-camouflaged nanoplatform for intravenous glucose-responsive insulin delivery[J]. Adv Funct Mater,2018,28(41):1802250.
    [22]
    Mohammadpour F,Hadizadeh F,Tafaghodi M,et al. Preparation,in vitro and in vivo evaluation of PLGA/chitosan based nano-complex as a novel insulin delivery formulation[J]. Int J Pharm,2019,572:118710.
    [23]
    Gu Z,Aimetti AA,Wang Q,et al. Injectable nano-network for glucose-mediated insulin delivery[J]. ACS Nano,2013,7(5):4194-4201.
    [24]
    Zhao L,Xiao C,Wang L,et al. Glucose-sensitive polymer nanoparticles for self-regulated drug delivery[J]. Chem Commun (Camb),2016,52(49):7633-7652.
    [25]
    Zhou X,Wu H,Long R,et al. Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation[J]. J Nanobiotechnology,2020,18(1):96.
    [26]
    Tai W,Mo R,Di J,et al. Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin[J]. Biomacromolecules,2014,15(10):3495-3502.
    [27]
    Zhou K,Wang Y,Huang X,et al. Tunable,ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells[J]. Angew Chem Int Ed Engl,2011,50(27):6109-6114.
    [28]
    Luo FQ,Chen GJ,Xu W,et al. Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery[J]. Nano Res,2021,14(8):2689-2696.
    [29]
    Tong ZZ,Zhou JY,Huang RS,et al. Dual-responsive supramolecular self-assembly of inclusion complex of an azobenzene-ended poly(ε-caprolactone) with a water-soluble pillar[6]Arene and its application in controlled drug release[J]. J Polym Sci Part A:Polym Chem,2017,55(15):2477-2482.
    [30]
    Zuo M,Qian W,Xu Z,et al. Multiresponsive supramolecular theranostic nanoplatform based on pillar[5]Arene and diphenylboronic acid derivatives for integrated glucose sensing and insulin delivery[J]. Small,2018,14(38):e1801942.
    [31]
    Lin YH,Hu W,Bai XW,et al. Glucose- and pH-responsive supramolecular polymer vesicles based on host-guest interaction for transcutaneous delivery of insulin[J]. ACS Appl Bio Mater,2020,3(9):6376-6383.
    [32]
    Ma RJ,Sun XC,Liu XJ,et al. Complex micelles with glucose-responsive shells for self-regulated release of glibenclamide[J]. Aust J Chem,2014,67(1):127.
    [33]
    Gaballa H,Theato P. Glucose-responsive polymeric micelles via boronic acid-diol complexation for insulin delivery at neutral pH[J]. Biomacromolecules,2019,20(2):871-881.
    [34]
    Li X,Shang H,Wu W,et al. Glucose-responsive micelles for controlled insulin release based on transformation from amphiphilic to double hydrophilic[J]. J Nanosci Nanotechnol,2016,16(6):5457-5463.
    [35]
    Chen Y,Li P,Modica JA,et al. Acid-resistant mesoporous metal-organic framework toward oral insulin delivery:protein encapsulation,protection,and release[J]. J Am Chem Soc,2018,140(17):5678-5681.
    [36]
    Zhang C,Hong S,Liu MD,et al. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery[J]. J Control Release,2020,320:159-167.
    [37]
    Yang XX,Feng P,Cao J,et al. Composition-engineered metal-organic framework-based microneedles for glucose-mediated transdermal insulin delivery[J]. ACS Appl Mater Interfaces,2020,12(12):13613-13621.
    [38]
    Jamwal S,Ram B,Ranote S,et al. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery[J]. Int J Biol Macromol,2019,123:968-978.
    [39]
    Zhang G,Ji Y,Li X,et al. Polymer-covalent organic frameworks composites for glucose and pH dual-responsive insulin delivery in mice[J]. Adv Healthc Mater,2020,9(14):e2000221.
    [40]
    Chen WH,Luo GF,Vázquez-González M,et al. Glucose-responsive metal-organic-framework nanoparticles act as "Smart" sense-and-treat carriers [J]. ACS Nano,2018,12(8):7538-7545.
    [41]
    Patel A,Sant S. Hypoxic tumor microenvironment:opportunities to develop targeted therapies[J]. Biotechnol Adv,2016,34(5):803-812.
    [42]
    Thambi T,Deepagan VG,Yoon HY,et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery[J]. Biomaterials,2014,35(5):1735-1743.
    [43]
    Yu JC,Qian CG,Zhang YQ,et al. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery[J]. Nano Lett,2017,17(2):733-739.
    [44]
    Yu JC,Zhang YQ,Ye YQ,et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery[J]. Proc Natl Acad Sci USA,2015,112(27):8260-8265.
    [45]
    Thambi T,Deepagan VG,Yoon HY,et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery[J]. Biomaterials,2014,35(5):1735-1743.
    [46]
    Matsumoto A,Ishii T,Nishida J,et al. A synthetic approach toward a self-regulated insulin delivery system[J]. Angew Chem Int Ed Engl,2012,51(9):2124-2128.
    [47]
    Bratlie KM,York RL,Invernale MA,et al. Materials for diabetes therapeutics[J]. Adv Healthc Mater,2012,1(3):267-284.
    [48]
    Ye YQ,Yu JC,Wang C,et al.Microneedles integrated with pancreatic cells and synthetic glucose-signal amplifiers for smart insulin delivery [J]. Adv Mater,2016,28(16):3115-3121.
    [49]
    Yao Y,Zhao LY,Yang JJ,et al. Glucose-responsive vehicles containing phenylborate ester for controlled insulin release at neutral pH[J]. Biomacromolecules,2012,13(6):1837-1844.
    [50]
    Wang J,Ye Y,Yu J,et al. Core-shell microneedle gel for self-regulated insulin delivery[J]. ACS Nano,2018,12(3):2466-2473.
    [51]
    Huang Q,Wang L,Yu H,et al. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy[J]. J Control Release,2019,305:50-64.
    [52]
    Hu XL,Yu JC,Qian CG,et al. H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery[J]. ACS Nano,2017,11(1):613-620.
    [53]
    Hei MY,Wu HJ,Fu Y,et al. Phenylboronic acid functionalized silica nanoparticles with enlarged ordered mesopores for efficient insulin loading and controlled release[J]. J Drug Deliv Sci Technol,2019,51:320-326.
    [54]
    Xu B,Jiang G,Yu W,et al. H2O2-Responsive mesoporous silica nanoparticles integrated with microneedle patches for the glucose-monitored transdermal delivery of insulin[J]. J Mater Chem B,2017,5(41):8200-8208.
    [55]
    Yoshida K,Awaji K,Shimizu S,et al. Preparation of microparticles capable of glucose-induced insulin release under physiological conditions[J]. Polymers,2018,10(10):1164.
    [56]
    Tong ZZ,Zhou JY,Zhong JX,et al. Glucose- and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats[J]. ACS Appl Mater Interfaces,2018,10(23):20014-20024.
    [57]
    Wang YX,Fan YT,Zhang MH,et al. Glycopolypeptide nanocarriers based on dynamic covalent bonds for glucose dual-responsiveness and self-regulated release of insulin in diabetic rats[J]. Biomacromolecules,2020,21(4):1507-1515.
    [58]
    Hou L,Zheng YZ,Wang YC,et al. Self-regulated carboxyphenylboronic acid-modified mesoporous silica nanoparticles with “touch switch” releasing property for insulin delivery[J]. ACS Appl Mater Interfaces,2018,10(26):21927-21938.
    [59]
    Zhang Y,Wang J,Yu J,et al. Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade-triggered insulin delivery[J]. Small,2018,14(14):e1704181.
    [60]
    Liu F,Bai L,Zhang H,et al. Smart H2O2-responsive drug delivery system made by halloysite nanotubes and carbohydrate polymers[J]. ACS Appl Mater Interfaces,2017,9(37):31626-31633.
    [61]
    Shen D,Yu HJ,Wang L,et al. Glucose-responsive hydrogel-based microneedles containing phenylborate ester bonds and N-isopropylacrylamide moieties and their transdermal drug delivery properties[J]. Eur Polym J,2021,148:110348.
    [62]
    Wang C,Ye YQ,Sun WJ,et al. Red blood cells for glucose-responsive insulin delivery[J]. Adv Mater,2017,29(18):1606617.
    [63]
    Sokolovska J,Isajevs S,Baumane L,et al. Enhanced expression of xanthine oxidase and NO synthases causing the overproduction of NO in kidneys of diabetic animals can be reduced by 1,4-dihydropyridines[J]. Nitric Oxide,2013,31:S15.
  • Related Articles

    [1]TAO Junjie, YANG Jie, WEN Xiaodong. Studies on the chemical constituents in the aerial parts of Paris polyphylla var. Yunnanensis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 454-460. DOI: 10.11665/j.issn.1000-5048.20200410
    [2]WANG Xiaoying, WANG Xiaying, QIU Liangzhen, OUYANG Huizhi, XU Wei. Cytotoxicity and cellular uptake of paclitaxel-loaded carboxymethyl chitosan-rhein polymeric micelles in MCF-7 cells[J]. Journal of China Pharmaceutical University, 2020, 51(1): 33-37. DOI: 10.11665/j.issn.1000-5048.20200106
    [3]CHENG Weihua, WANG Wenqian, SHANG Hai, ZHANG Hongwu, GUO Qiang, CHEN Hong, ZOU Zhongmei. Synthesis and cytotoxicity study of cembrane triazole derivatives[J]. Journal of China Pharmaceutical University, 2018, 49(1): 56-63. DOI: 10.11665/j.issn.1000-5048.20180108
    [4]TANG Yong, LIAO Shengrong, LI Jinsheng, LIU Yonghong. Design, synthesis and cytotoxic activities of fluorine-containing 2, 5-diketopiperazine derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(4): 412-421. DOI: 10.11665/j.issn.1000-5048.20160405
    [5]SUN Hao, YANG Jiapei, MAO Yong, WANG Dandan, YU Feng. Involvement of Fas-dependent pathway in rhein-induced apoptosis of HK-2 cells[J]. Journal of China Pharmaceutical University, 2015, 46(4): 469-475. DOI: 10.11665/j.issn.1000-5048.20150414
    [6]WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403
    [7]FEI Jia, SUN Min-jie, PING Qi-neng, ZHANG Can. Preparation,characterization and safety evaluation for N-octyl-N-quaternary ammonium chitosan/CMCNa composite micelles[J]. Journal of China Pharmaceutical University, 2012, 43(4): 318-324.
    [8]SHEN Yan, LI Qian, FAN Da, LI Rui-jun, TU Jia-sheng. Influencing factors of hydrophobic modified hyaluronic acid-based cationic micelles and cell targeting in siRNA transfection[J]. Journal of China Pharmaceutical University, 2012, 43(2): 124-129.
    [9]GUO Zhong, ZHAO Jin, MA Jian-xiu, FU Si-wu. Effects of toxin A from Clostridium difficile on SMMC-7721 cells proliferation and apoptosis[J]. Journal of China Pharmaceutical University, 2009, 40(3): 250-253.
    [10]Structure-Cytotoxic Activity Relationships of Diterpenoid Tanshinones from Salvias[J]. Journal of China Pharmaceutical University, 2002, (1): 8-14.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return